Wealth Enhancement Advisory Services’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.6K Sell
39,828
-44,166
-53% -$64K ﹤0.01% 4033
2026
Q2
$113K Buy
83,994
+21,629
+35% +$27.6K ﹤0.01% 3772
2026
Q1
$71.1K Buy
62,365
+4,836
+8% +$5.95K ﹤0.01% 3384
2025
Q4
$75.9K Sell
57,529
-18,220
-24% -$25.4K ﹤0.01% 3485
2025
Q3
$117K Buy
75,749
+38,755
+105% +$53.2K ﹤0.01% 3301
2025
Q2
$50.3K Sell
36,994
-37,712
-50% -$51.6K ﹤0.01% 3226
2025
Q1
$124K Buy
74,706
+45,798
+158% +$75.4K ﹤0.01% 2724
2024
Q4
$42.5K Buy
28,908
+12,417
+75% +$19K ﹤0.01% 2879
2024
Q3
$24.6K Sell
16,491
-180
-1% -$267 ﹤0.01% 2657
2024
Q2
$20.8K Buy
+16,671
New +$21.6K ﹤0.01% 2487
2023
Q4
– Sell
-10,969
Closed -$17.6K – 2409
2023
Q3
$17.6K Buy
+10,969
New +$20K ﹤0.01% 2200

Other funds holding OPK

Wealth Enhancement Advisory Services's OPK Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Opko Health (OPK) stake by 53% in Q3 2026, selling an estimated $64K and leaving 39,828 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4033.

Wealth Enhancement Advisory Services first reported a position in OPK in Q3 2023 and has held it in 11 quarters since. The position peaked at $124K in Q1 2025. 222 funds tracked by Wall St. Rank hold OPK as of Q3 2026.

  • Wealth Enhancement Advisory Services held 39,828 shares of Opko Health worth $54.6K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 44,166 Opko Health shares in Q3 2026, an estimated $64K.
  • Opko Health made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4033 holding.
  • Wealth Enhancement Advisory Services first reported a position in Opko Health in Q3 2023 and has held it in 11 quarters since.
  • Wealth Enhancement Advisory Services's Opko Health position peaked at $124K in Q1 2025.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.